About: Novel therapeutics for metastatic renal cell carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Novel therapeutics for metastatic renal cell carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on May 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) bài báo khoa học (vi) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в травні 2009 (uk) مقالة علمية نشرت في مايو 2009 (ar) scientific article published on May 2009 (en)
publication date	wds:Q37463888-D1873D3C-E176-410F-9509-E8B56A4A66D1
publication date	2009-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37463888-E34CC590-FA19-4B6D-9BFA-7CADF675E70D
language of work or name	English
cites work	wds:Q37463888-15B7A287-EE9C-4619-89F8-6B86B2599DCA wds:Q37463888-3520D760-045A-4100-80B9-7BC1FB7B2146 wds:Q37463888-35B3102D-8C4F-492C-8A0C-CA40143CEA6E wds:Q37463888-451C4DB0-12D4-4B97-8F1D-9B31DFA434A8 wds:Q37463888-4E11AE49-2138-41F7-87ED-F3E97E690352 wds:Q37463888-52A77487-F2CB-4AD5-88AF-6C90C583A365 wds:Q37463888-53B1D115-4E22-4D39-A755-F3F3928C8D0F wds:Q37463888-73B63E52-B14A-4074-8E80-AD4BBA98028C wds:Q37463888-8726DF0E-1D90-4CCE-807B-E5DD0CF06C4B wds:Q37463888-9ED41BBD-2B2D-4E47-919C-2303353AE1CD wds:Q37463888-EBA916CD-0983-477C-B1C4-79BA3734D712 wds:Q37463888-F0CC585E-495E-45CF-A375-9E216EB00C43
cites work	Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206 Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study Sunitinib versus interferon alfa in metastatic renal-cell carcinoma Sorafenib in advanced clear-cell renal-cell carcinoma Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Cancer statistics, 2007 Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma A new method of estimating United States and state-level cancer incidence counts for the current calendar year Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia. Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy
author name string	wds:Q37463888-DC61A60D-223C-4C1D-AD8C-C341F41EC435 wds:Q37463888-FD090757-549F-4E5F-A262-E132B2457B13
author name string	Thomas E Hutson Robert A Figlin
rdfs:label	Novel therapeutics for metastatic renal cell carcinoma (en) Novel therapeutics for metastatic renal cell carcinoma (nl) Novel therapeutics for metastatic renal cell carcinoma (ast)
skos:prefLabel	Novel therapeutics for metastatic renal cell carcinoma (en) Novel therapeutics for metastatic renal cell carcinoma (nl) Novel therapeutics for metastatic renal cell carcinoma (ast)
name	Novel therapeutics for metastatic renal cell carcinoma (en) Novel therapeutics for metastatic renal cell carcinoma (nl) Novel therapeutics for metastatic renal cell carcinoma (ast)
title	wds:Q37463888-F098EF10-7FD1-455E-B785-225935E5A4D8
title	Novel therapeutics for metastatic renal cell carcinoma (en)
page(s)	wds:Q37463888-E0C2F78F-DA3C-4C32-9DF7-FFDB416AB040
page(s)	2361-2367
instance of	wds:Q37463888-103787DF-0913-4D79-8EB3-5FEA31C51399 wds:Q37463888-ac2432f5-7dac-4ad9-ad04-12f2ebfea524
instance of	review article scholarly article
PubMed ID	wds:Q37463888-E708BB5E-2062-4FD5-AF3B-DFA60F43293E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19402059
PubMed ID	19402059
published in	wds:Q37463888-BE8AD75D-96AC-4518-892C-30A921B0E637
published in	Cancer
issue	wds:Q37463888-D34629CC-B5EB-4A45-9943-557008397702
volume	wds:Q37463888-DD85E743-749E-41EB-8E9F-21A064211411
issue	10 Suppl
volume	115
DOI	wds:Q37463888-B53F8F93-3901-4C7E-BB23-FB95A1BD2586
DOI	http://dx.doi.org/10.1002/CNCR.24235
DOI	10.1002/CNCR.24235
ResearchGate publication ID	wds:Q37463888-F041011C-275B-45C0-AA13-D742DF19A5FA
ResearchGate publication ID	24376924
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37463888
is cites work of	Treatment of metastatic renal cell carcinoma. Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer Renal cell carcinoma Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma ARHGAP24 inhibits cell cycle progression, induces apoptosis and suppresses invasion in renal cell carcinoma DW-MRI of the urogenital tract: applications in oncology. TNIP1 Inhibits Proliferation And Promotes Apoptosis In Clear Cell Renal Carcinoma Through Targeting C/Ebpβ MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
is cites work of	wds:Q37588375-1397845A-2961-466E-9802-FA4ADB1BADC2 wds:Q34256443-3DA0B369-72AB-419F-9AFD-F7014F7AABBE wds:Q37748477-93A1765B-0577-4C10-875F-0269318E3C41 wds:Q38425940-7F70F762-E133-4F28-84D9-9F93A4B3C445 wds:Q82656838-EE67BB28-37A8-4F4F-B5D4-2BF46C91F50C wds:Q91828628-DDFC5FA4-5250-47F1-96D2-A0F58BD464F5 wds:Q92920319-51950AC1-8B42-414C-8798-ECD9CCF7DC66 wds:Q33396965-B82ED099-C1D9-4AD8-A584-F77B428B05F5 wds:Q37364606-FD7AFAAD-7519-4A13-BC56-ED6D0EFE7904

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software